On the afternoon of the 24th July 2012 at the Alexander Hotel, Merrion Square, Dublin, Genable will host a two hour presentation for interested parties on Gene Therapy for Ophthalmic Disease.
The program for the afternoon is as follows:
14.00 Welcome Address, Dr. Jason Loveridge CEO Genable Technologies
14.10 Gene therapy for retinal disease - the Genable approach, Prof. Jane Farrar CSO Genable Technologies
14.25 Gene therapy - a regulatory viewpoint, Prof. Alan Boyd Genable Technologies
14.40 Retinal pigmentosa - the patients perspective, Avril Daly CEO Fighting Blindness Ireland
14.50 Genable Technologies, a brief overview, Dr. Jason Loveridge
15.15 Afternoon tea
Should you be interested in attending could you please contact Genable staff at firstname.lastname@example.org before the 15th July 2012.
We look forward to meeting with you personally on the 24th.